ARCHIVES

NCI awards $42 million for prevention trials consortium.

This article is from The Cancer Letter archive.

Vol. 29 No. 45 | December 5, 2003

Download PDF Visit The Full Archive

Related Articles

PRI Purchased By DynCorp; NCI Is Assured No Changes Will Be Made At Frederick

April 13, 1990

ODAC Reviews Post-Marketing Studies for Eight Indications

February 21, 2003

FA Drug Approval on Activity, Rather Than Survival Urged By NCU

January 13, 1989

Cancer Prevention: NSABP Publishes P-1 Data, Finds Risk Of Breast Cancer Cut By 49 Percent

September 18, 1998

Provenge Prolonged Prostate Cancer Survival By Seven Months, Study Finds

September 26, 2003

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

December 30, 2011